Devastating infectious diseases cause suffering and death for millions of people around the globe. For many years, most of the investment in addressing these global health challenges was focused on basic disease research, while nearly all product development efforts were focused on larger markets in the developed world.

 

At IDRI, they are the bridge between knowledge and action. They combine their passion for improving human health with the understanding that it is not just what we know about disease, but what we do to change its course that will have the greatest impact. Developing products that solve intractable global health challenges is what they do, and they have a track record of doing it successfully. Their unique product-based approach to fighting infectious diseases has already yielded novel diagnostics, vaccines, and treatment strategies that are protecting and saving lives.

 

With deep relationships in the academic and corporate arenas, IDRI unites the best of the research and product development communities. Their partnerships with businesses, nonprofit foundations, and government agencies give them unprecedented access to cutting-edge technology and financial support.

 

They believe a holistic approach - combining the high-quality science of a research organization with the product development capabilities of a biotech company - will help them reach their goal of creating new diagnostics, drugs and vaccines to help those who need it most.